NCT05670470View on ClinicalTrials.gov

A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

January 15, 2023

Study Completion Date

January 31, 2023

Conditions
Bowel Preparation
Interventions
DRUG

CTP0303

Subjects who are randomized into group CTP0303 will receive bowel preparation from evening to next morning.

DRUG

Orafang Tab

Subjects who are randomized into group Orafang Tab will receive bowel preparation from evening to next morning.

Trial Locations (1)

05278

Kyung Hee University Hospital at Gangdong, Seoul

All Listed Sponsors
lead

Taejoon Pharmaceutical Co., Ltd.

INDUSTRY